Clinical data | |
---|---|
ATC code | None |
Identifiers | |
|
|
CAS Number | 69924-29-4 |
PubChem (CID) | 115077 |
ChemSpider | 102983 |
UNII | X9BMD58553 |
Chemical and physical data | |
Formula | C25H37NO2 |
Molar mass | 383.567 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Quadazocine (WIN-44,441) is an opioid antagonist of the benzomorphan family which is used in scientific research. It acts as a silent antagonist at all three of the major opioid receptors—μ, κ, and δ, but with a significant preference in affinity for the μ receptor and the κ2 subtype. As such, it has been touted as a "κ2-selective" antagonist, though, of course, this is not entirely accurate on account of its similar affinity for the μ receptor. As would be expected, quadazocine reverses the effects (e.g., analgesia) of opioid agonists like morphine and fentanyl in animals.